> MT < great report and enthusiasm, nice to see the passion and commitment.
same goes for the founder and previous CEO Robert Grey adding another 1 m shares to his 20% holdings.
Like you i was around at 2013 buying for 4-5 c'. selling in the 30 c' plus.
IMO this is a bit too early to re entering, YES they have completed the shift to the USA, they have refined the
operations and cut on costs and stock. they have come out with Tacera pulse software.
ALL great foundation for the future, the right industry in the right market. that's the positive
on the hesitant side, i worry about lack of capital ( negative cash flow) required for marketing and sales team to generate profits.
large contracts take a long time to be assessed signed and execute a legging factor of at least a year.
I do not count or invest on the possibility of a takeover, we have been there in the past ( was it hill ?)
I would rather err on the side of caution, there could be a CR on the cards, I believe the market is fearing it.
Share price can go lower before it starts to move upward on positive news.
This company will not move on speculation for a bright future, investors have been disappointed in the past
with the lack of news, and good news in particular.
I do have over 500,000 shares currently but will not add, until good news eventuate.
- Forums
- ASX - By Stock
- AZV
- Azure Healthcare Revisited
Azure Healthcare Revisited, page-6
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AZV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online